Newamsterdam Pharma Co. N.V.

Biotechnology • Healthcare • Naarden, Netherlands • NAMSW (NGM)

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

31 35 206 2971 Gooimeer 2-35, Netherlands

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

NewAmsterdam Pharma Company N.V. (NAMS) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Yahoo Finance • Nov 5

NewAmsterdam Pharma Company Grants Inducement Share Options to New Hires | NAMS Stock News - Quiver Quantitative

Quiver Quantitative • Dec 5

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

MarketBeat • Dec 11

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire • Dec 5

Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site - PR Newswire

PR Newswire • Aug 21

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has NewAmsterdam Pharma Co N.V. had layoffs?

No layoff events have been recorded for NewAmsterdam Pharma Co N.V. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does NewAmsterdam Pharma Co N.V. have?

NewAmsterdam Pharma Co N.V. has approximately 68 employees.

What industry is NewAmsterdam Pharma Co N.V. in?

NewAmsterdam Pharma Co N.V. operates in the Biotechnology industry, within the Healthcare sector.

Is NewAmsterdam Pharma Co N.V. a publicly traded company?

Yes, NewAmsterdam Pharma Co N.V. is publicly traded under the ticker symbol NAMSW on the NGM.

Where is NewAmsterdam Pharma Co N.V. headquartered?

NewAmsterdam Pharma Co N.V. is headquartered in Naarden, Netherlands at Gooimeer 2-35, Netherlands.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.